SB 1867
Perry’s bill adding THC variants to Penalty Group 2
Died in committee
Verdict: No flags
Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
Caption
relating to the addition of certain substances to Penalty Group 2 of the Texas Controlled Substances Act.
Caption from analyzed text · version I.
Summary
Delta-8, delta-10, HHC and friends become controlled substances.
The bill adds a long list of THC variants to Penalty Group 2 of the Texas Controlled Substances Act, including delta-8, delta-10, THCP, HHC, THC-O acetate, THC metabolites, and several synthetic cannabinoids. It touches anyone who makes, sells, or holds products with these substances, which this text now treats as controlled substances in Penalty Group 2. Starting September 1, 2025, conduct involving these listed substances falls under the Penalty Group 2 offenses, and the new rules apply only to conduct on or after that date.
Labels
Labels: NEVER GOT A HEARING. Filed Mar 4, 2025 and referred to the Senate State Affairs committee. No public hearing. The bill died.
Receipt
The receipt
89R-SB1867 · 2025-03-04
SOLD BY
ITEM
relating to the addition of certain substances to Penalty Group 2 of the Texas Controlled Substances Act.
WHAT IT DOES
Delta-8, delta-10, HHC and friends become controlled substances.
The bill adds a long list of THC variants to Penalty Group 2 of the Texas Controlled Substances Act, including delta-8, delta-10, THCP, HHC, THC-O acetate, THC metabolites, and several synthetic cannabinoids. It touches anyone who makes, sells, or holds products with these substances, which this text now treats as controlled substances in Penalty Group 2. Starting September 1, 2025, conduct involving these listed substances falls under the Penalty Group 2 offenses, and the new rules apply only to conduct on or after that date.
CHARGES
[ ] NONE FOUND
TOTAL
No fiscal note in the loaded record.
HISTORY
- Received by the Secretary of the Senate
- Filed
- Read first time
- Referred to State Affairs
FILED UNDER
No verified beat found.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
CAMPAIGN PAID FOR BY
Donors
Not tied to this bill.
Sources
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Jul 1, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Texans for Lawsuit Reform PAC$60,000.00
Texans for Lawsuit Reform PAC
$60,000.00
- Cash
- $60,000.00
- Paid by others
- $0.00
- Total
- $60,000.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Nov 13, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100983698, 101007598, 101030579, 101072377.
Ryan Texas PAC$35,000.00
Ryan Texas PAC
$35,000.00
- Cash
- $35,000.00
- Paid by others
- $0.00
- Total
- $35,000.00
Also funds 25 other sitting lawmakers.
Derived recipient stock · Sep 23, 2024 to Oct 22, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 13, 2024 to Mar 12, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100983698, 101057700.
Fort Stockton Holdings LP$25,000.00
Fort Stockton Holdings LP
$25,000.00
- Cash
- $25,000.00
- Paid by others
- $0.00
- Total
- $25,000.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · on Nov 23, 2024. State data as of Nov 4, 2026.
Name match, not a verified identity: normalized filed name and state.
Sources
Derived itemized flow · on Nov 23, 2024. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100983698.
Missing data does not establish zero giving. Display amounts are rounded.
Texans for Lawsuit Reform PAC
$60,000.00
- Cash
- $60,000.00
- Paid by others
- $0.00
- Total
- $60,000.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Nov 13, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100983698, 101007598, 101030579, 101072377.
Ryan Texas PAC
$35,000.00
- Cash
- $35,000.00
- Paid by others
- $0.00
- Total
- $35,000.00
Also funds 25 other sitting lawmakers.
Derived recipient stock · Sep 23, 2024 to Oct 22, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamSources
Derived itemized flow · Dec 13, 2024 to Mar 12, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100983698, 101057700.
Fort Stockton Holdings LP
$25,000.00
- Cash
- $25,000.00
- Paid by others
- $0.00
- Total
- $25,000.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · on Nov 23, 2024. State data as of Nov 4, 2026.
Name match, not a verified identity: normalized filed name and state.
Sources
Derived itemized flow · on Nov 23, 2024. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100983698.
Votes
No floor vote loaded for this bill.
Fiscal
No fiscal note in the loaded record.
How this was graded
Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.
Sources
Texas Senate · Filed Mar 4, 2025
03/17/2025 S Referred to State Affairs
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.
Senate committee · State Affairs · Final status: Died in committee
Subjects
Alcoholism & Drug Abuse
Crimes--Drugs
Text
The text as introduced · 1,473 words
89R15191 CJD-F By: Perry S.B. No. 1867 A BILL TO BE ENTITLED AN ACT relating to the addition of certain substances to Penalty Group 2 of the Texas Controlled Substances Act. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 481.103(a), Health and Safety Code, is amended to read as follows: (a) Penalty Group 2 consists of: (1) any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: 5-(2-aminopropyl)benzofuran (5-APB); 6-(2-aminopropyl)benzofuran (6-APB); 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB); 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB); 5-(2-aminopropyl)indole (5-IT,5-API); 6-(2-aminopropyl)indole (6-IT,6-API); 1-(benzofuran-5-yl)-N-methylpropan-2-amine (5-MAPB); 1-(benzofuran-6-yl)-N-methylpropan-2-amine (6-MAPB); Benzothiophenylcyclohexylpiperidine (BTCP); 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran- 4-ethanamine (trade or other name: Bromo-DragonFLY); Desoxypipradrol (2-benzhydrylpiperidine); 2, 5-dimethoxyamphetamine (some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); Diphenylprolinol (diphenyl(pyrrolidin-2-yl) methanol, D2PM); Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product (some trade or other names for Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)- tetrahydrocannabinol); Ethylamine Analog of Phencyclidine (some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1- phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE); 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone (trade or other name: methoxetamine); Ibogaine (some trade or other names: 7-Ethyl-6, 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); 5-iodo-2-aminoindane (5-IAI); Mescaline; 5-methoxy-3, 4-methylenedioxy amphetamine; 4-methoxyamphetamine (some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA); 4-methoxymethamphetamine (PMMA); 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone (some trade and other names: 2-MeO-ketamine; methoxyketamine); 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, PPMP); 4-methyl-2, 5-dimethoxyamphetamine (some trade and other names: 4-methyl-2, 5-dimethoxy-alpha- methylphenethylamine; "DOM"; "STP"); 3,4-methylenedioxy methamphetamine (MDMA, MDM); 3,4-methylenedioxy amphetamine; 3,4-methylenedioxy N-ethylamphetamine (Also known as N-ethyl MDA); 5,6-methylenedioxy-2-aminoindane (MDAI); Nabilone (Another name for nabilone: (+)-trans- 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; N-benzylpiperazine (some trade or other names: BZP; 1-benzylpiperazine); N-ethyl-3-piperidyl benzilate; N-hydroxy-3,4-methylenedioxyamphetamine (Also known as N-hydroxy MDA); 4-methylaminorex; N-methyl-3-piperidyl benzilate; Parahexyl (some trade or other names: 3-Hexyl-1- hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] pyran; Synhexyl); 1-Phenylcyclohexylamine; 1-Piperidinocyclohexanecarbonitrile (PCC); Pyrrolidine Analog of Phencyclidine (some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); Tetrahydrocannabinols, other than marihuana, and synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as: delta-1 cis or trans tetrahydrocannabinol, and their optical isomers; delta-6 cis or trans tetrahydrocannabinol, and their optical isomers; delta-3, 4 cis or trans tetrahydrocannabinol, and its optical isomers; [ or ] delta-5, cis or trans tetrahydrocannabinol, and their optical isomers; delta-6a, cis or trans tetrahydrocannabinol, and their optical isomers; delta-7, cis or trans tetrahydrocannabinol, and their optical isomers; delta-7a, cis or trans tetrahydrocannabinol, and their optical isomers; delta-8, cis or trans tetrahydrocannabinol, and their optical isomers; delta-9, cis or trans tetrahydrocannabinol, and their optical isomers; delta-10, cis or trans tetrahydrocannabinol, and their optical isomers; delta-10a, cis or trans tetrahydrocannabinol, and their optical isomers; delta-11, cis or trans tetrahydrocannabinol, and their optical isomers; delta-11-Hydroxy-tetrahydrocannabinol; exo-tetrahydrocannabinol; 1-pentyl-3-(1-naphthoyl) indole (JWH-018); 1-butyl-3-(1-naphthoyl) indole (JWH-073); 1-pentyl-3-(4-methoxynaphthoyl) indole (14-JWH-200); 1-pentyl-3-(2-methoxynaphthoyl) indole (JWH-250); 1-pentyl-3-(4-chloronaphthoyl) indole (JWH-398); 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3- hydroxycyclohexyl]-phenol (CP-47,497); (6aR,10aR)-9-(hydroxymethyl)-6,6- dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol (HU-210); (6a,10a)-9-(hydroxymethyl)-6,6- dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo [c]chromen-1-ol (HU-211); tetrahydrocannabivarins, including delta-8 tetrahydrocannabivarin; metabolites of tetrahydrocannabinol, including 11-hydroxy-tetrahydrocannabinol, 3-hydroxy-tetrahydrocannabinol, and 7-hydroxy-tetrahydrocannabinol; hexahydrocannabiphorol-o-ester; hydrogenated forms of tetrahydrocannabinol, including hexahydrocannabinol, hexahydrocannabiphorol, and hexahydrocannabihexol; hydrogenated forms of hexahydrocannabinol (HHC), including 8-hydroxyhexahydrocannabinol and 10-hydroxyhexahydrocannabinol; ester forms of tetrahydrocannabinol, including delta-8 THC-O-acetate, delta-9 THC-O-acetate, and hexahydrocannabinol-O-acetate; tetrahydrocannabinols with alkyl chain of four or more carbon atoms, including tetrahydrocannabiphorols (THCP), tetrahydrocannabioctyls, tetrahydrocannabihexols (THCH), tetrahydrocannabidiol (THC-JD), and tetrahydrocannabutols; tetrahydrocannabinol acetate (THC-O); tetrahydrocannabinol methyl ester; N-(1-Amino-1-methyl-ethyl)-5-fluoropen tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (XRL-11 &15); N-(1-Amino-1-methyl-ethyl)-5-fluoropen tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (UR-144); N-(1-Amino-1-methyl-ethyl)-5-fluoropen tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (FUB-144); N-(1-Amino-1-methyl-ethyl)-5-fluoropen tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (AMB-FUBINACA); (3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4- tetrahydroisoquinolin-6-amine) (THJ-220); (3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4- tetrahydroisoquinolin-6-amine) (RCS-4); Cannabicycloheptanone; or compounds of these structures, regardless of numerical designation of atomic positions, since nomenclature of these substances is not internationally standardized; Thiophene Analog of Phencyclidine (some trade or other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl Analog of Phencyclidine; TPCP, TCP); 1-pyrrolidine (some trade or other name: TCPy); 1-(3-trifluoromethylphenyl)piperazine (trade or other name: TFMPP); and 3,4,5-trimethoxy amphetamine; (2) Phenylacetone (some trade or other names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl ketone); (3) unless specifically excepted or unless listed in another Penalty Group, a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant or stimulant effect on the central nervous system: Aminorex (some trade or other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine); Amphetamine, its salts, optical isomers, and salts of optical isomers; Cathinone (some trade or other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2- aminopropiophenone); Etaqualone and its salts; Etorphine Hydrochloride; Fenethylline and its salts; Lisdexamfetamine, including its salts, isomers, and salts of isomers; Mecloqualone and its salts; Methaqualone and its salts; Methcathinone (some trade or other names: 2- methylamino-propiophenone; alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone, N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431); N-Ethylamphetamine, its salts, optical isomers, and salts of optical isomers; and N,N-dimethylamphetamine (some trade or other names: N,N,alpha-trimethylbenzeneethanamine; N,N,alpha-trimethylphenethylamine), its salts, optical isomers, and salts of optical isomers; (4) any compound structurally derived from 2-aminopropanal by substitution at the 1-position with any monocyclic or fused-polycyclic ring system, including: (A) compounds further modified by: (i) substitution in the ring system to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), whether or not further substituted in the ring system by other substituents; (ii) substitution at the 3-position with an alkyl substituent; or (iii) substitution at the 2-amino nitrogen atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or inclusion of the 2-amino nitrogen atom in a cyclic structure; and (B) by example, compounds such as: 4-Methylmethcathinone (Also known as Mephedrone); 3,4-Dimethylmethcathinone (Also known as 3,4-DMMC); 3-Fluoromethcathinone (Also known as 3-FMC); 4-Fluoromethcathinone (Also known as Flephedrone); 3,4-Methylenedioxy-N-methylcathinone (Also known as Methylone); 3,4-Methylenedioxypyrovalerone (Also known as MDPV); alpha-Pyrrolidinopentiophenone (Also known as alpha-PVP); Naphthylpyrovalerone (Also known as Naphyrone); alpha-Methylamino-valerophenone (Also known as Pentedrone); beta-Keto-N-methylbenzodioxolylpropylamine (Also known as Butylone); beta-Keto-N-methylbenzodioxolylpentanamine (Also known as Pentylone); beta-Keto-Ethylbenzodioxolylbutanamine (Also known as Eutylone); and 3,4-methylenedioxy-N-ethylcathinone (Also known as Ethylone); (5) any compound structurally derived from tryptamine (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine: (A) by modification in any of the following ways: (i) by substitution at the amine nitrogen atom of the sidechain to any extent with alkyl or alkenyl groups or by inclusion of the amine nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure; (ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain (alpha-position) with an alkyl or alkenyl group; (iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, alkylenedioxy, or halide substituents; or (iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent; and (B) including: (i) ethers and esters of the controlled substances listed in this subdivision; and (ii) by example, compounds such as: alpha-ethyltryptamine; alpha-methyltryptamine; Bufotenine (some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- dimethyltryptamine; mappine); Diethyltryptamine (some trade and other names: N, N-Diethyltryptamine, DET); Dimethyltryptamine (trade or other name: DMT); 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DiPT); O-Acetylpsilocin (Trade or other name: 4-Aco-DMT); Psilocin; and Psilocybin; (6) 2,5-Dimethoxyphenethylamine and any compound structurally derived from 2,5-Dimethoxyphenethylamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as: 4-Bromo-2,5-dimethoxyphenethylamine (trade or other name: 2C-B); 4-Chloro-2,5-dimethoxyphenethylamine (trade or other name: 2C-C); 2,5-Dimethoxy-4-methylphenethylamine (trade or other name: 2C-D); 4-Ethyl-2,5-dimethoxyphenethylamine (trade or other name: 2C-E); 4-Iodo-2,5-dimethoxyphenethylamine (trade or other name: 2C-I); 2,5-Dimethoxy-4-nitrophenethylamine (trade or other name: 2C-N); 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade or other name: 2C-P); 4-Ethylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-2); 4-Isopropylthio-2,5-dimethoxyphenethylamine (trade or other name: 2C-T-4); and 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (trade or other name: 2C-T-7); and (7) 2,5-Dimethoxyamphetamine and any compound structurally derived from 2,5-Dimethoxyamphetamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as: 4-Ethylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-2); 4-Isopropylthio-2,5-dimethoxyamphetamine (trade or other name: Aleph-4); 4-Bromo-2,5-dimethoxyamphetamine (trade or other name: DOB); 4-Chloro-2,5-dimethoxyamphetamine (trade or other name: DOC); 2,5-Dimethoxy-4-ethylamphetamine (trade or other name: DOET); 4-Iodo-2,5-dimethoxyamphetamine (trade or other name: DOI); 2,5-Dimethoxy-4-methylamphetamine (trade or other name: DOM); 2,5-Dimethoxy-4-nitroamphetamine (trade or other name: DON); 4-Isopropyl-2,5-dimethoxyamphetamine (trade or other name: DOIP); and 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or other name: DOPR). SECTION 2. The change in law made by this Act applies only to an offense committed on or after the effective date of this Act. An offense committed before the effective date of this Act is governed by the law in effect on the date the offense was committed, and the former law is continued in effect for that purpose. For purposes of this section, an offense was committed before the effective date of this Act if any element of the offense occurred before that date. SECTION 3. This Act takes effect September 1, 2025.